Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients (VANCS II)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Cristiane Maciel Zambolim, Instituto do Cancer do Estado de São Paulo
ClinicalTrials.gov Identifier:
NCT01718613
First received: October 29, 2012
Last updated: May 18, 2015
Last verified: May 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2015
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)